α2-Plasmin inhibitor is a substrate for tissue transglutaminase: An in vitro study

Thrombosis Research

Volumn 99, Issue 4, 2000, Pages 399-406

  Hevessy, Zsuzsa ^a   Patthy, András ^b   Kárpáti, Levente ^a   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

2 Plasmin inhibitor; Factor XIII; Protein cross linking; Transglutaminase

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; GLYCINE ETHYL ESTER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AMINE TRANSPORT; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FIBRIN DEPOSITION; GUINEA PIG; HUMAN; HUMAN TISSUE; INCUBATION TIME; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; REACTION ANALYSIS; SEQUENCE ANALYSIS; STOICHIOMETRY;

AMINES; ANIMALS; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; BASE SEQUENCE; BINDING SITES; COAGULANTS; FACTOR XIII; FIBRIN; GLYCINE; GUINEA PIGS; HUMANS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; SERINE PROTEINASE INHIBITORS; SUBSTRATE SPECIFICITY; TRANSGLUTAMINASES;

EID: 0034663359     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00261-9     Document Type: Article

References (35)

1. Folk J.E. Mechanism and basis for specificity of transglutaminase catalyzed epsilon(gamma glutamyl) lysine bond formation. Adv Enzymol. 54:1983;1-56.
2. Lorand L., Conrad S.M. Transglutaminases. Mol Cell Biochem. 58:1984;9-35.
3. Aeschlimann D., Paulsson M. Transglutaminases. protein cross-linking enzymes in tissues and body fluids Thromb Haemost. 71:1994;402-415.
4. Muszbek L., Yee V.C., Hevessy Z. Blood coagulation factor XIII. Structure and function Thromb Res. 94:1999;271-305.
5. 2-plasmin inhibitor to fibrin by fibrin stabilising factor. J Clin Invest. 65:1980;290-297.
6. Aeschlimann D., Paulsson M. Cross-linking of laminin-nidogen complex by tissue transglutaminase. a novel mechanism for basement membrane stabilisation J Biol Chem. 266:1991;15308-15317.
7. Aeschlimann D., Wetterwald A., Fleisch H., Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol. 120:1993;1461-1470.
8. Fésüs L., Davies P.J.A., Piacentini M. Apoptosis. molecular mechanism in programmed cell death Eur J Cell Biol. 56:1991;170-177.
9. Chen J.S., Mehta K. Tissue transglutaminase. an enzyme with a split personality Int J Biochem Cell Biol. 8:1999;817-836.
10. Shainoff J.R., Urbanic D.A., DiBello D.M. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. J Biol Chem. 266:1991;6429-6437.
11. Siebenlist K.R., Mosesson M.W. Factors affecting gamma-chain multimer formation in cross-linked fibrin. Biochemistry. 31:1992;936-941.
12. Chung S.I. Comparative studies on tissue transglutaminase and factor XIII. Ann NY Acad Sci. 202:1972;240-255.
13. Murthy S.N.P., Lorand L. Cross-linked Aα·γ chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase. Proc Natl Acad Sci USA. 87:1990;9679-9682.
14. Gorman J.J., Folk J.E. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. J Biol Chem. 256:1981;2712-2715.
15. Gorman J.J., Folk J.E. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of guinea pig liver enzyme. J Biol Chem. 259:1984;9007-9010.
16. 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta. 661:1981;280-286.
17. 125I-containing acylating agent. Biochem J. 133:1973;529-538.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
19. Lorand L., Campbell-Wilkes L.K., Cooperstein L. A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem. 50:1972;623-631.
20. Muszbek L., Polgár J., Fésüs L. Kinetic determination of blood coagulation factor XIII in plasma. Clin Chem. 31:1985;35-40.
21. Kárpáti L., Muszbek L. An improved photometric assay for the determination of blood coagulation factor XIII in plasma. Thromb Haemost. Suppl):1999;698a.
22. 2-plasmin inhibitor in human plasma. Biochem J. 291:1993;623-625.
23. 2-antiplasmin N-terminal and reactive site sequence. FEBS Lett. 312:1992;100-104.
24. 2-plasmin inhibitor. J Biochem. 106:1989;703-707.
25. Borth W., Chang V., Bishop P., Harpel P.C. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. J Biol Chem. 266:1991;18149-18153.
26. 2-plasmin inhibitor to fibrin catalysed by activated fibrin-stabilising factor. J Biol Chem. 257:1982;14767-14772.
27. 2-plasmin inhibitor to fibrinogen by fibrin stabilising factor. Biochim Biophys Acta. 706:1982;158-164.
28. 2-antiplasmin and plasmin. Stopped-flow fluorescence kinetics. FEBS Lett. 387:1996;58-62.
29. 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site. Biochemistry. 26:1987;5133-5140.
30. Martinez J., Rich E., Barsigian C. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. J Biol Chem. 264:1989;20502-20508.
31. Martinez J., Chalupowicz D.G., Roush R.K., Sheth A., Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry. 33:1994;2538-2545.
32. Shainoff J.R., Page I.H. Deposition of modified fibrinogen within the aortic intima. Atherosclerosis. 16:1972;287-305.
33. Shainoff J.R., Valenzuela R., Urbanic D.A., DiBello P.M., Lucas F.V., Graor R. Fibrinogen Aα and γ-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease. Blood Coag Fibrinolysis. 1:1990;499-503.
34. Valenzuela R., Shainoff J.R., DiBello P.M., Urbanic D.A., Anderson J.M., Matsueda G.R., Kudryk B.J. Immunoelectrophoretic and immunohistochemical characterisation of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prothesis pseudointimas. Am J Pathol. 141:1992;861-879.
35. Greenberg C.S., Achyuthan K.E., Borowitz M.J., Shuman M.A. The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilisation. Blood. 70:1987;702-709.